CVS Health is on a roll. After it rang up more than $153 billion in total sales last year -- making it one of the largest retail operations in the world -- industry watchers expect the company's ...

CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...

So you are wondering whether CVS Health at around $77.79 is still a smart buy after its big run, or if you are showing up late to the party, this breakdown will help you separate real value from just ...

Diversified healthcare company CVS Health (NYSE:CVS) reported in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ ...

Numbers can lie -- yet they're the best first step in determining whether a stock is a buy. In this series, we use some carefully chosen metrics to size up a stock's true value based on the following ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CVS Health easily beat fourth-quarter ...

CVS Health is being accused by the U.S. Justice Department of filling illegal prescriptions to gain profit and reach ...

CVS Health (CVS 0.43%) is on a roll. After it rang up more than $153 billion in total sales last year -- making it one of the largest retail operations in the world -- industry watchers expect the ...

Let's take a look. Numbers can lie -- yet they're the best first step in determining whether a stock is a buy. In this series, we use some carefully chosen metrics to size up a stock's true value ...

FILE - In this Wednesday, Feb. 3, 2021 file photo, a CVS pharmacy is seen in Los Angeles. CVS Health Corporation (CVS) on Tuesday, Feb. 16 reported a fourth-quarter net income of $973 million. (AP ...

CVS Average Diluted Shares Outstanding (Quarterly). Data by YCharts. $5 billion: That's how much total capital will be returned to shareholders in 2016 through a combination of dividends and buybacks.